Abstract Library

#1327 Is Screening of Young Asymptomatic MEN1 Patients Necessary?

Introduction: Recent clinical practice guidelines recommend that routine screening of MEN1 mutation carriers should start at the age of 5 years to detect MEN1-associated tumors which is controversial in the scientific community.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Manoharan J, Lopez C, Albers M, Bollmann C, Slater E,

Keywords: Screening, MEN1,

#442 Low Diagnostic Accuracy of Tumor Markers for the Annual Screening of Pancreatic Neuroendocrine Tumors in MEN-1 Patients

Introduction: The use of tumor markers for annual screening for pancreatic neuroendocrine tumors (pNET) in Multiple Endocrine Neoplasia type 1 (MEN-1) is debatable because of low-level evidence and high costs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: De Laat J, Weijmans M, Hermus A, Dekkers O, De Herder W,

Keywords: MEN-1, tumor marker, annual screening, Chromogranin A,